PARP-1 (Poly[ADP-Ribose] Polymerase-1).
作者信息
Alves-Lopes Rhéure, Touyz Rhian M
机构信息
From the Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, United Kingdom.
出版信息
Hypertension. 2018 Nov;72(5):1087-1089. doi: 10.1161/HYPERTENSIONAHA.118.11830.
Abstract
摘要
相似文献
1
PARP-1 (Poly[ADP-Ribose] Polymerase-1).聚（ADP - 核糖）聚合酶 -1（PARP -1）
Hypertension. 2018 Nov;72(5):1087-1089. doi: 10.1161/HYPERTENSIONAHA.118.11830.
2
PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.PARP-1（多聚[ADP-核糖]聚合酶 1）抑制可保护小鼠免受 Ang II（血管紧张素 II）诱导的腹主动脉瘤。
Hypertension. 2018 Nov;72(5):1189-1199. doi: 10.1161/HYPERTENSIONAHA.118.11184.
3
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.聚（ADP-核糖）聚合酶-1缺陷型小鼠可免受血管紧张素II诱导的心脏肥大。
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1545-53. doi: 10.1152/ajpheart.01124.2005. Epub 2006 Apr 21.
4
Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.体外生成蛋白质连接的和无蛋白质的单聚、寡聚和多聚（ADP-核糖）
Methods Mol Biol. 2018;1813:91-108. doi: 10.1007/978-1-4939-8588-3_7.
5
Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.聚腺苷二磷酸核糖聚合酶抑制剂PJ34可消除胸主动脉缺血再灌注后的全身促炎反应。
J Am Coll Surg. 2006 Jul;203(1):44-53. doi: 10.1016/j.jamcollsurg.2006.04.004. Epub 2006 May 30.
6
Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.在布氏锥虫前循环期，ADP-核糖代谢紊乱伴细胞核内聚（ADP-核糖）积累，在过氧化氢存在的情况下会导致不同的细胞死亡途径。
Parasit Vectors. 2016 Mar 23;9:173. doi: 10.1186/s13071-016-1461-1.
7
Poly(ADP-ribosylation) and genomic stability.多聚（ADP - 核糖基化）与基因组稳定性
Biochem Cell Biol. 2005 Jun;83(3):263-9. doi: 10.1139/o05-039.
8
Quartz Crystal Microbalance Detection of Poly(ADP-ribose) Polymerase-1 Based on Gold Nanorods Signal Amplification.基于金纳米棒信号放大的石英晶体微天平检测聚（ADP-核糖）聚合酶-1
Anal Chem. 2019 Sep 3;91(17):11038-11044. doi: 10.1021/acs.analchem.9b01366. Epub 2019 Jul 11.
9
Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.聚（ADP-核糖）聚合酶（PARP）生成的ADP-核糖聚合物的链长分析，作为β-NAD⁺和酶浓度的函数。
IUBMB Life. 2000 Aug;50(2):145-9. doi: 10.1080/713803695.
10
Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells.人多聚（ADP - 核糖）聚合酶在转染大鼠肿瘤细胞中的功能性过表达。
Carcinogenesis. 1997 Apr;18(4):663-8. doi: 10.1093/carcin/18.4.663.
引用本文的文献
1
Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis.聚（ADP-核糖）聚合酶-1 在血栓形成中的调节作用。
J Thromb Thrombolysis. 2024 Jun;57(5):743-753. doi: 10.1007/s11239-024-02974-3. Epub 2024 May 24.
2
Role of PARP and TRPM2 in VEGF Inhibitor-Induced Vascular Dysfunction.PARP 和 TRPM2 在 VEGF 抑制剂诱导的血管功能障碍中的作用。
J Am Heart Assoc. 2023 Feb 21;12(4):e027769. doi: 10.1161/JAHA.122.027769. Epub 2023 Feb 20.
3
Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency.慢性静脉功能不全中瓣膜功能不全患者的组织重塑和 DNA 损伤增加。
J Cell Mol Med. 2021 Aug;25(16):7878-7889. doi: 10.1111/jcmm.16711. Epub 2021 Jun 20.
4
Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer.聚（ADP-核糖）聚合酶-1（PARP-1）基因rs1136410 C>T多态性对癌症发生发展的影响。
J Cell Mol Med. 2020 Dec;24(24):14639-14644. doi: 10.1111/jcmm.16027. Epub 2020 Oct 27.
5
Poly(ADP-ribose) polymerase inhibition: past, present and future.聚（ADP-核糖）聚合酶抑制：过去、现在和未来。
Nat Rev Drug Discov. 2020 Oct;19(10):711-736. doi: 10.1038/s41573-020-0076-6. Epub 2020 Sep 3.
本文引用的文献
1
PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.PARP-1（多聚[ADP-核糖]聚合酶 1）抑制可保护小鼠免受 Ang II（血管紧张素 II）诱导的腹主动脉瘤。
Hypertension. 2018 Nov;72(5):1189-1199. doi: 10.1161/HYPERTENSIONAHA.118.11184.
2
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚（ADP-核糖）聚合酶（PARP）和 PARP 抑制剂：作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
3
Molecular targets in aortic aneurysm for establishing novel management paradigms.用于建立新型治疗模式的主动脉瘤分子靶点
J Thorac Dis. 2017 Nov;9(11):4708-4722. doi: 10.21037/jtd.2017.10.63.
4
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension.高血压中的氧化应激、炎症与血管衰老
Hypertension. 2017 Oct;70(4):660-667. doi: 10.1161/HYPERTENSIONAHA.117.07802. Epub 2017 Aug 7.
5
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.聚（ADP - 核糖）聚合酶1（PARP1）在DNA修复和染色质重塑中的多方面作用。
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621. doi: 10.1038/nrm.2017.53. Epub 2017 Jul 5.
6
Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats.慢性PARP-1抑制可减轻自发性高血压大鼠的颈动脉血管重塑和背侧海马体的氧化损伤。
PLoS One. 2017 Mar 24;12(3):e0174401. doi: 10.1371/journal.pone.0174401. eCollection 2017.
7
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.聚腺苷二磷酸核糖聚合酶抑制剂在非肿瘤性疾病治疗中的再利用机会。
Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26.
8
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.聚（ADP-核糖）聚合酶与ADP-核糖基化：将分子功能与生物学结果相联系的最新进展
Genes Dev. 2017 Jan 15;31(2):101-126. doi: 10.1101/gad.291518.116.
9
Identification of the ADPR binding pocket in the NUDT9 homology domain of TRPM2.TRPM2的NUDT9同源结构域中ADPR结合口袋的鉴定。
J Gen Physiol. 2017 Feb;149(2):219-235. doi: 10.1085/jgp.201611675. Epub 2017 Jan 20.
10
The calcium chloride-induced rodent model of abdominal aortic aneurysm.氯化钙诱导的腹主动脉瘤啮齿动物模型。
Atherosclerosis. 2013 Jan;226(1):29-39. doi: 10.1016/j.atherosclerosis.2012.09.010. Epub 2012 Sep 21.
Zotero 插件